Sinunasale Neoplasien: Neues aus der WHO 2022

Agaimy A (2023)


Publication Type: Journal article, Review article

Publication year: 2023

Journal

Book Volume: 44

Pages Range: 233-239

Journal Issue: 4

DOI: 10.1007/s00292-023-01202-8

Abstract

The pathology of poorly differentiated sinonasal malignancies has undergone a dynamic evolution during the last decade, resulting in a refined, mostly genetically or etiologically oriented classification of neoplasms in the historical spectrum of sinonasal undifferentiated carcinoma (NUT carcinoma, SWI-/SNF-deficient carcinomas, and others). Moreover, some new entities have been established, while others could be further delineated and better characterized. A highlight of the new classification is the inclusion of SWI/SNF (SMARCB1 or SMARCA4)-deficient carcinomas into a separate category. In addition, carcinomas with DEK::AFF2 fusions have been included as a provisional entity in the spectrum of nonkeratinizing squamous cell carcinoma. This review addresses the major changes in the classification of sinonasal tract neoplasms in the new WHO classification.

Authors with CRIS profile

How to cite

APA:

Agaimy, A. (2023). Sinunasale Neoplasien: Neues aus der WHO 2022. Die Pathologie, 44(4), 233-239. https://doi.org/10.1007/s00292-023-01202-8

MLA:

Agaimy, Abbas. "Sinunasale Neoplasien: Neues aus der WHO 2022." Die Pathologie 44.4 (2023): 233-239.

BibTeX: Download